 22. The participant has abnormal laboratory values that suggest a clinically significant underlying disease, or the participant has the following lab abnormalities at the time of screening or baseline examination: alanine aminotransferase ALT or aspartate aminotransferase AST 1.5 × the upper limits of normal, or differential white blood count monocytes the lower limit of normal. 